Header Logo

Connection

Co-Authors

This is a "connection" page, showing publications co-authored by Brian Mittman and Erin Hahn.
Connection Strength

1.326
  1. A study protocol for a cluster randomized pragmatic trial for comparing strategies for implementing primary HPV testing for routine cervical cancer screening in a large health care system. Contemp Clin Trials. 2023 01; 124:106994.
    View in: PubMed
    Score: 0.216
  2. Trends in HPV vaccine administration and HPV vaccine coverage in children by race/ethnicity and socioeconomic status during the COVID-19 pandemic in an integrated health care system in California. Vaccine. 2022 11 02; 40(46):6575-6580.
    View in: PubMed
    Score: 0.215
  3. De-implementation and substitution of clinical care processes: stakeholder perspectives on the transition to primary human papillomavirus (HPV) testing for cervical cancer screening. Implement Sci Commun. 2021 Sep 23; 2(1):108.
    View in: PubMed
    Score: 0.200
  4. Patient and Physician Perspectives of Deprescribing Potentially Inappropriate Medications in Older Adults with a History of Falls: a Qualitative Study. J Gen Intern Med. 2021 Jan 19.
    View in: PubMed
    Score: 0.191
  5. Anxiety, Culture, and Expectations: Oncologist-Perceived Factors Associated With Use of Nonrecommended Serum Tumor Marker Tests for Surveillance of Early-Stage Breast Cancer. J Oncol Pract. 2017 01; 13(1):e77-e90.
    View in: PubMed
    Score: 0.143
  6. Cervical Cancer Screening: Patient Perspectives on Transitioning to Primary High-Risk Human Papillomavirus Testing Alone. Perm J. 2024 Oct 24; 1-8.
    View in: PubMed
    Score: 0.062
  7. Primary Human Papillomavirus Screening: Women's Perceptions of New Cervical Cancer Screening Recommendations. J Womens Health (Larchmt). 2024 Dec; 33(12):1614-1624.
    View in: PubMed
    Score: 0.061
  8. Potentially Harmful Medication Dispenses After a Fall or Hip Fracture: A Mixed Methods Study of a Commonly Used Quality Measure. Jt Comm J Qual Patient Saf. 2022 Apr; 48(4):222-232.
    View in: PubMed
    Score: 0.051
  9. Laboratory monitoring to reduce adverse drug-related events: a mixed methods study. J Manag Care Spec Pharm. 2022 Jan; 28(1):16-25.
    View in: PubMed
    Score: 0.051
  10. Impact of COVID-19 on Cervical Cancer Screening Rates Among Women Aged 21-65 Years in a Large Integrated Health Care System - Southern California, January 1-September 30, 2019, and January 1-September 30, 2020. MMWR Morb Mortal Wkly Rep. 2021 Jan 29; 70(4):109-113.
    View in: PubMed
    Score: 0.048
  11. Embedded Research in the Learning Healthcare System: Ongoing Challenges and Recommendations for Researchers, Clinicians, and Health System Leaders. J Gen Intern Med. 2020 12; 35(12):3675-3680.
    View in: PubMed
    Score: 0.046
  12. Follow-up of Abnormal Estimated GFR Results Within a Large Integrated Health Care Delivery System: A Mixed-Methods Study. Am J Kidney Dis. 2019 11; 74(5):589-600.
    View in: PubMed
    Score: 0.043

© 2024 Kaiser Permanente